Market Size in 2021 | Market Forecast in 2028 | CAGR (in %) | Base Year |
---|---|---|---|
USD 1.08 Billion | USD 15.84 Billion | 29.50% | 2021 |
FrequentlyAsked Questions
Recently the government has started to fund projects in CRISPR genome edition or engineering providing ample support for organizations to conduct research. Secondly its implementation in agricultural sector as well is helping the market grow.
As per Zion Market Research, the size of the global CRISPR Genome Editing market is expected to attain a value of USD 15.84 billion by 2028, growing at a rate of growth at the rate of 29.50% CAGR during the forecast period from USD 1.08 billion in 2021.
North America is expected to lead the global CRISPR Genome Editing market due to significant investments made by pharmaceutical and biotech businesses, rise in per capita income, enhanced health systems, accessibility of therapies, and affordability of state-of-the-art testing facilities and organizations in the region.
Insights from Zion Market Research list Thermo Fisher Scientific (US), Merck KGaA (Germany), GenScript (China), Sangamo Therapeutics (US), Lonza (Switzerland), CRISPR Therapeutics AG (Switzerland), and Precision Biosciences (US) as the major companies that are into intense research in order to capture the widest variety of CRISPR genome editing applications.
RelatedNews
HappyClients
Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651
3rd Floor,
Mrunal Paradise, Opp Maharaja Hotel,
Pimple Gurav, Pune 411061,
Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008
US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com
We have secured system to process your transaction.
Our support available to help you 24 hours a day, five days a week.
Monday - Friday: 9AM - 6PM
Saturday - Sunday: Closed